Heron Therapeutics Inc
General ticker "HRTX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $225.0M
Heron Therapeutics Inc does not follow the US Stock Market performance with the rate: -9.8%.
Estimated limits based on current volatility of 3.4%: low 1.50$, high 1.61$
Factors to consider:
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.16$, 3.27$]
- 2024-12-30 to 2025-12-30 estimated range: [1.55$, 3.95$]
Financial Metrics affecting the HRTX estimates:
- Negative: Non-GAAP EPS, $ of -0.86 <= 0.10
- Negative: Operating profit margin, % of -46.54 <= 1.03
- Negative: Operating cash flow per share per price, % of -21.52 <= 2.35
- Negative: negative Net income
- Positive: Inventory ratio change, % of -8.74 <= -1.03
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term HRTX quotes
Long-term HRTX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $86.35MM | $107.67MM | $127.04MM |
| Operating Expenses | $304.17MM | $282.33MM | $237.66MM |
| Operating Income | $-217.83MM | $-174.66MM | $-110.61MM |
| Non-Operating Income | $-2.85MM | $-7.37MM | $0.06MM |
| Interest Expense | $2.41MM | $2.47MM | $3.87MM |
| R&D Expense | $130.82MM | $107.51MM | $55.90MM |
| Income(Loss) | $-220.68MM | $-182.02MM | $-110.56MM |
| Profit(Loss) | $-220.68MM | $-182.02MM | $-110.56MM |
| Stockholders Equity | $77.57MM | $13.57MM | $-33.97MM |
| Inventory | $48.38MM | $54.57MM | $42.11MM |
| Assets | $305.71MM | $250.95MM | $222.51MM |
| Operating Cash Flow | $-203.35MM | $-146.91MM | $-58.79MM |
| Capital expenditure | $3.02MM | $1.82MM | $1.54MM |
| Investing Cash Flow | $32.73MM | $-3.32MM | $18.00MM |
| Financing Cash Flow | $156.03MM | $75.06MM | $54.11MM |
| Earnings Per Share* | $-2.21 | $-1.24 | $-0.80 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.